Datametrex: COVID-19 Testing Continues To Thrive Despite Vaccines – The Daily Dive
For the final episode of the trading week, we see the return of Datametrex AI (TSXV: DM) CEO Marshall Gunter to the Daily Dive. Within, we sit down with Marshall to discuss the recent strong financials put forth by the company, and address the current state of COVID-19 testing being conducted by the company. We then move on to discuss Graph Blockchain, the current state of the firms AI divisions, and what we can expect in the months ahead from the company.
Datametrex AI is a firm primarily focused on technology, via its flagship subsidiary Nexalogy, which is focused on artificial intelligence and machine learning. Recently, the company stepped up to the plate amid the COVID-19 pandemic, distributing its COVID-19 test kits to numerous partners throughout Canada. Clients under its health division include several Canadian mine operators, the film and television production sector in Toronto and Vancouver, and most notably, Air Canada.
FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
